Follow
Carles Monterrubio
Carles Monterrubio
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery
C Monterrubio, G Pascual-Pasto, F Cano, M Vila-Ubach, A Manzanares, ...
Biomaterials 79, 69-78, 2016
492016
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal …
C Monterrubio, S Paco, NG Olaciregui, G Pascual-Pasto, M Vila-Ubach, ...
Journal of Controlled Release 255, 108-119, 2017
472017
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas
A Bukchin, G Pascual-Pasto, M Cuadrado-Vilanova, H Castillo-Ecija, ...
Journal of controlled release 276, 59-71, 2018
352018
Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy
KV Floros, TL Lochmann, B Hu, C Monterrubio, MT Hughes, JD Wells, ...
Proceedings of the National Academy of Sciences 115 (11), E2594-E2603, 2018
322018
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
G Pascual-Pasto, NG Olaciregui, M Vila-Ubach, S Paco, C Monterrubio, ...
Cancer letters 380 (1), 10-19, 2016
242016
Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas
H Castillo‐Ecija, G Pascual‐Pasto, S Perez‐Jaume, C Resa‐Pares, ...
The Journal of Pathology: Clinical Research 7 (4), 338-349, 2021
142021
Combined microdialysis-tumor homogenate method for the study of the steady state compartmental distribution of a hydrophobic anticancer drug in patient-derived xenografts
C Monterrubio, S Paco, M Vila-Ubach, E Rodríguez, R Glisoni, C Lavarino, ...
Pharmaceutical research 32, 2889-2900, 2015
132015
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution
H Castillo-Ecija, C Monterrubio, G Pascual-Pasto, S Gomez-Gonzalez, ...
Journal of controlled release 324, 440-449, 2020
82020
Tissue Compatibility of SN‐38‐Loaded Anticancer Nanofiber Matrices
A Manzanares, CA Restrepo‐Perdomo, G Botteri, H Castillo‐Ecija, ...
Advanced healthcare materials 7 (15), 1800255, 2018
72018
Prognostic value of xenograft engraftment in patients with metastatic high‐risk neuroblastoma
R Aschero, H Castillo‐Ecija, M Baulenas‐Farres, C Resa‐Pares, ...
Pediatric Blood & Cancer 70 (6), e30318, 2023
22023
DIPG-43. Prolonged Convection-Enhanced Delivery in the Pons with SN-38 Loaded nanoparticles and Irinotecan
AC Sewing, NG Olaciregui, C Monterrubio, G Kaspers, J Mora, ...
Neuro-Oncology 19 (Suppl 4), iv14, 2017
12017
HG-96FUNCTIONAL INTEGRITY OF THE BLOOD-BRAIN BARRIER IN H3. 3K27M DIPG XENOGRAFTS
NG Olaciregui, AM La Madrid, C Monterrubio, G Pascual-Pasto, ...
Neuro-oncology 18 (Suppl 3), iii70, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–12